JP Patent

JP5632367B2 — Ｂｉｂｗ２９９２を含有する固形医薬製剤

Assigned to ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング · Expires 2014-11-26 · 11y expired

What this patent protects

Patent listed against afatinib-dimaleate.

Drugs covered by this patent

afatinib-dimaleate (AFATINIB DIMALEATE)

Patent Metadata

Patent number: JP5632367B2
Jurisdiction: JP
Classification: —
Expires: 2014-11-26
Drug substance claim: No
Drug product claim: No
Assignee: ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.